Testing effectiveness (Phase 2)Study completedNCT04993755
What this trial is testing
A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD
Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal Dementia
Transposon Therapeutics, Inc. 42